Found: 21
Select item for more details and to access through your institution.
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. 392, doi. 10.1093/oncolo/oyad302
- By:
- Publication type:
- Article
Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3949, doi. 10.3390/cancers15153949
- By:
- Publication type:
- Article
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38342-7
- By:
- Publication type:
- Article
Identification of epithelial and mesenchymal circulating tumor cells in clonal lineage of an aggressive prostate cancer case.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00289-1
- By:
- Publication type:
- Article
Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation.
- Published in:
- BJU International, 2022, v. 129, n. 5, p. 610, doi. 10.1111/bju.15541
- By:
- Publication type:
- Article
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26415-4
- By:
- Publication type:
- Article
Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint Inhibitors.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 9, p. e2122998, doi. 10.1001/jamanetworkopen.2021.22998
- By:
- Publication type:
- Article
Decoding the evolutionary response to prostate cancer therapy by plasma genome sequencing.
- Published in:
- Genome Biology, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s13059-020-02045-9
- By:
- Publication type:
- Article
Nivolumab for the Treatment of Patients with Metastatic Non‐Clear Cell Renal Cell Carcinoma (nccRCC): A Single‐Institutional Experience and Literature Meta‐Analysis.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 252, doi. 10.1634/theoncologist.2019-0372
- By:
- Publication type:
- Article
Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II Trial.
- Published in:
- Oncologist, 2015, v. 20, n. 10, p. 1140, doi. 10.1634/theoncologist.2015-0143
- By:
- Publication type:
- Article
8-Chloroadenosine Sensitivity in Renal Cell Carcinoma Is Associated with AMPK Activation and mTOR Pathway Inhibition.
- Published in:
- PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0135962
- By:
- Publication type:
- Article
Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 252, p. 1, doi. 10.1126/scitranslmed.3009332
- By:
- Publication type:
- Article
Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 11, p. 1379, doi. 10.1093/neuonc/nos158
- By:
- Publication type:
- Article
Circulating Biomarkers of Response to Sunitinib in Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Molecular Diagnosis & Therapy, 2012, v. 16, n. 3, p. 151, doi. 10.1007/BF03262203
- By:
- Publication type:
- Article
Innovations and Challenges in Renal Cancer: Summary Statement From the Third Cambridge Conference.
- Published in:
- 2009
- By:
- Publication type:
- Proceeding
Circulating Biomarkers for Vascular Endothelial Growth Factor Inhibitors in Renal Cell Carcinoma.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 10, p. 2346, doi. 10.1002/cncr.24228
- By:
- Publication type:
- Article
A Ligand Peptide Motif Selected from a Cancer Patient Is a Receptor-Interacting Site within Human Interleukin-11.
- Published in:
- PLoS ONE, 2008, v. 3, n. 10, p. 1, doi. 10.1371/journal.pone.0003452
- By:
- Publication type:
- Article
Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms.
- Published in:
- 2008
- By:
- Publication type:
- journal article
UFT-induced haemolytic anaemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2001, v. 47, n. 3, p. 280, doi. 10.1007/s002800000195
- By:
- Publication type:
- Article